Journal of Surgical Oncology

Aims & Scope

The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies.

As an international journal, the editors encourage participation from leading surgeons around the world.

The JSO is the representative journal for the World Federation of Surgical Oncology Societies.

Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials.

Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year.

These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.00

SJR (SCImago Journal Rank)

Year	Value
2024	0.741

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	136

Journal Rank

Year	Value
2024	7527

Journal Citation Indicator

Year	Value
2024	2235

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

  Citation: 861

  Authors: S.R., E.J., F., T.A., N.J.

• The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery

  Citation: 676

  Authors: Boudewijn E., J. Sven D., Merlijn, Joost R., Peter J.K., Clemens W.G.M., John V., Cornelis J.H., Alexander L.

• Tumor measurement in the nude mouse

  Citation: 499

  Authors: David M., Charles, Marie C., Frank E.

• Granular cell tumor: A clinicopathologic study of 110 patients

  Citation: 490

  Authors: Ernest E., R. G. Frederick, Michael D., Benton E., Scott, Geoffrey, Byungkyu

• Merkel cell carcinoma: Changing incidence trends

  Citation: 446

  Authors: Nicole C.

• Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

  Citation: 442

  Authors: Frank A., Louis, Thomas, John D., William, Jordan, Fairooz, William, Somnath, Herbert

• Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

  Citation: 394

  Authors: Takamaru, David N., Stephanie R., Thomas B., Stewart J., Ann M., Joan M., Seth P., Donald L., Eleftherios P., Joseph P., Norman

• Gastric cancer epidemiology and risk factors

  Citation: 389

  Authors: Douglas E., Manish A.

• Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

  Citation: 364

  Authors: Guy, Anthony, James, David, Paul, Geoff, Giuseppe, Bruce

• Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)

  Citation: 362

  Authors: A., M., G.K., D., W., Y., M., R.P., L.H., E.M.

---